JNJ-64304500

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JNJ-64304500, covering 2022-02-17 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease [Phase 2]